Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oral Anticoagulant Therapy”

158 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 158 results

Not applicableUnknownNCT03124030
What this trial is testing

Intra- and Post- Operative Bleeding After Simple Dental Extraction in Direct Oral Anticoagulant Therapy

Who this might be right for
Anticoagulant-induced BleedingDental Diseases
University of Trieste 128
Not applicableStudy completedNCT04580589
What this trial is testing

DOAC ADRs Retrospective Study on Genetic Variations

Who this might be right for
Drug-Related Side Effects and Adverse ReactionsTreatment Failure
Cipherome, Inc. 210
Large-scale testing (Phase 3)UnknownNCT00125671
What this trial is testing

Warfarin and Antiplatelet Vascular Evaluation

Who this might be right for
Peripheral Vascular DiseasesCardiovascular Diseases
Anand, Sonia, M.D. 2,400
Testing effectiveness (Phase 2)Study completedNCT04041843
What this trial is testing

Oral Anticoagulant Apixaban for Treatment of Venous Thromboembolism

Who this might be right for
Venous Thromboembolism
New York Medical College 25
Not applicableUnknownNCT03392948
What this trial is testing

PERcutaneouS Coronary intErventions in Patients Treated With Oral Anticoagulant Therapy

Who this might be right for
Acute Myocardial InfarctionUnstable AnginaChronic Stable Angina
Italian Society of Invasive Cardiology 1,080
Not applicableUnknownNCT03271450
What this trial is testing

The DARE Warfarin CER Study

Who this might be right for
Deep Venous ThrombosisPulmonary Embolism
Brigham and Women's Hospital 416,000
Large-scale testing (Phase 3)Looking for participantsNCT06878066
What this trial is testing

Thrombolysis in Factor Xa-inhibitors Trial

Who this might be right for
StrokeStroke (in Patients With Atrial Fibrillation)Ischemic Stroke+6 more
Guri Hagberg 300
Post-approval studies (Phase 4)Study completedNCT00151853
What this trial is testing

Study Use of PPSB-SD and VP-VI in Patients With Anticoagulant Therapy and Undergoing Acute CPB Surgery

Who this might be right for
CPBOral Anticoagulant Therapy
Prothya Biosolutions 40
Early research (Phase 1)Study completedNCT03864406
What this trial is testing

Impact of Steady State Cobicistat and Darunavir/Cobicistat on the Pharmacokinetics and Pharmacodynamics of Oral Anticoagulants (Rivaroxaban, Apixaban) in Health Volunteers

Who this might be right for
Healthy Volunteers
National Institutes of Health Clinical Center (CC) 12
Not applicableLooking for participantsNCT06947707
What this trial is testing

Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients

Who this might be right for
Cerebral Venous ThrombosisAnticoagulants and Thrombotic DisordersAnticoagulation Treatment+6 more
Xuanwu Hospital, Beijing 1,486
Not applicableStudy completedNCT04234698
What this trial is testing

Patient Characteristics, Treatment Patterns And Incidence Of Events (Discontinuation, Persistence, Key Primary Clinical Outcomes) In NVAF Patients Initiating OAC Therapy In Colombia

Who this might be right for
Atrial Fibrillation
Pfizer 2,076
Large-scale testing (Phase 3)Not Yet RecruitingNCT06925698
What this trial is testing

Immunosuppressive Therapy Alone Versus Plus Oral Anticoagulation in the Treatment of VT Associated With Behcet's Disease

Who this might be right for
Behcet DiseaseBehcet Disease and Vascular InvolvementDeep Venous Thromboses+1 more
Marmara University 110
Not applicableNot Yet RecruitingNCT06290440
What this trial is testing

MEdication Counselling Models for Outpatient oRal antIcoaguLation

Who this might be right for
Anticoagulants; Circulating, Hemorrhagic Disorder
Gia Dinh People Hospital 360
Testing effectiveness (Phase 2)Study completedNCT00684307
What this trial is testing

Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation

Who this might be right for
Nonvalvular Atrial Fibrillation
AstraZeneca 1,084
Not applicableEnded earlyNCT03645564
What this trial is testing

Impact of the Information Follow-up Given to Patients on Their Disease Understanding and Therapeutic Adherence in Patients Under Direct Oral Anticoagulants and With Atrial Fibrillation in a Cardiology Department

Who this might be right for
Atrial Fibrillation
University Hospital, Bordeaux 221
Not applicableStudy completedNCT05471830
What this trial is testing

An Observational Study (Called RETAF-PS) Using a Patient Survey to Learn More About Treatment Outcomes in Patients With Irregular and Often Rapid Heartbeat (Atrial Fibrillation) Treated With Apixaban in a Real World Setting

Who this might be right for
Prevention of Thromboembolic EventsAtrial Fibrillation
Bayer 600
Not applicableEnrolling By InvitationNCT07159399
What this trial is testing

A Pharmacist-Led Education Program to Improve Adherence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation (AF)
National Taiwan University 400
Not applicableUnknownNCT03885180
What this trial is testing

Randomized Evaluation of D-dimer Guiding dUration of Oral antiCoagulation thErapy

Who this might be right for
Valve Heart DiseaseAnticoagulants; Increased
Wuhan Asia Heart Hospital 500
Not applicableStudy completedNCT04645537
What this trial is testing

Finnish AntiCoagulation in Atrial Fibrillation (FinACAF)

Who this might be right for
Atrial Fibrillation
Helsinki University Central Hospital 400,000
Large-scale testing (Phase 3)Looking for participantsNCT04867837
What this trial is testing

Study of OCTAPLEX in Patients With Acute Major Bleeding on DOAC Therapy With Factor Xa Inhibitor

Who this might be right for
Acute Major Bleeding
Octapharma 260
Load More Results